Yu Jinming

[Expert Profile] Yu Jinming, Chief Physician, Professor, Doctoral Supervisor, Academician of the Chinese Academy of Engineering, is an authoritative expert in radiation oncology in China, working at Shandong Cancer Hospital. He has long been dedicated to radiation therapy and comprehensive treatment of malignant pleural mesothelioma and difficult tumors, and is a leading figure in the discipline of radiation oncology in China.

[Education & Career] Professor Yu Jinming graduated from Shandong Medical University, completed systematic radiation oncology training at Shandong Cancer Hospital, and further studied at famous international cancer centers, systematically mastering cutting-edge international precision radiation therapy techniques. He has long served as President of Shandong Cancer Hospital, holding important academic positions including Chair of the Radiation Oncology Branch of the Chinese Medical Association. He was elected as an Academician of the Chinese Academy of Engineering in 2011, and is a respected discipline leader in the field of radiation oncology in China.

[Areas of Expertise] Professor Yu specializes in radiation therapy and comprehensive treatment of thoracic tumors such as malignant pleural mesothelioma, lung cancer, and esophageal cancer, as well as various difficult tumors. He has profound expertise in cutting-edge techniques such as radiation therapy combined with immunotherapy, biologically guided radiation therapy (BGRT), and adaptive radiation therapy. He pioneered and implemented the concept of "precision radiotherapy," excelling at developing individualized radiation therapy plans based on tumor biological characteristics and individual differences, maximizing normal tissue protection while improving tumor control rates, and helping numerous difficult tumor patients gain curative treatment opportunities.

[Academic Achievements & Industry Contributions] Professor Yu has led multiple cutting-edge radiation oncology research projects, systematically exploring innovative modalities such as radiotherapy combined with immunotherapy and biologically guided precision radiotherapy, with findings published in top international oncology journals and cited by international guidelines. He has led the development of Chinese radiation oncology-related guidelines and expert consensus statements, actively promoted the popularization of precision radiotherapy concepts and techniques nationwide, and led the establishment of a national radiation therapy quality control system, significantly improving the overall level and international status of radiation oncology in China.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of radiation oncology, Professor Yu has led his team in treating hundreds of thousands of patients with various tumors, with radiation therapy volume and quality ranking among the highest nationwide. Leading his team, he has developed precise and effective radiation therapy plans for countless difficult tumor patients, creating many treatment miracles. He has received multiple national awards including the National Science and Technology Progress Award, trained a large number of radiation oncology professionals, and is a truly deserving leading figure in the field of radiation oncology in China, deeply admired by patients and peers alike.

[Honors & Reputation] Professor Yu Jinming serves as President of Shandong Cancer Hospital and Academician of the Chinese Academy of Engineering, among other academic positions. He has presided over national-level major projects including the National Key R&D Program, and is an authoritative expert in the field of radiation oncology in China. He has profound expertise in radiation therapy for malignant pleural mesothelioma and difficult tumors, as well as precision radiotherapy. He pioneered and promoted the concept of precision radiotherapy, led multiple large-scale clinical studies that have rewritten radiation therapy guidelines, with findings published in top international journals and receiving the National Science and Technology Progress Award. For decades on the clinical front lines, he has helped numerous difficult tumor patients gain curative treatment opportunities through precision radiotherapy, trained a large number of radiation oncology professionals, and is deeply trusted by patients and respected by peers alike.